Fluoguide announced that FG001 has been awarded FDA Fast Track designation, in a major validation of its achievements to date in the fluorescence-guided surgery programmes. We view this as significant, because regulatory interactions will be crucial in enabling optimal design of a clinical programme, given the various novel elements of Fluoguide's plan. The shares are likely to be up double-digit % today.
LÄS MER
